Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. حسب Cathryn S. D. Maienza (20629929)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. حسب Hakim Ben Abdallah (14578241)

ABT199 inhibits ALK ^mutant kinase activity and decreases it phosphorylation. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Raw data. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Mean (95% CI) and standard deviation of Lumbar Lordosis angle(˚) between two groups pre and post 60 minutes of standing. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Mean (95% CI) and standard deviation of VAS Score (mm) before & after intervention between two group during 1-houre standing. Intervention: using footrest with/without changing arm... حسب Saeedeh Abbasi (9423189)

الموضوعات:

Data. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Co-Contraction index of right and left gluteus medius activity (MVC%) during 60 minutes standing (time- condition) between two groups (A: used the footrest intermittently, B: used... حسب Saeedeh Abbasi (9423189)

الموضوعات:

Example of a participant using the elevated surface (20 cm) during the intermittent footrest use (A) and the intermittent footrest use with arm flexion, hands crossed on the clavic... حسب Saeedeh Abbasi (9423189)

الموضوعات:

VAS score (mm) before & after intervention between two group (A: used the footrest intermittently, B: used the footrest with change arm positions) every 15 minutes during 60 minute... حسب Saeedeh Abbasi (9423189)

الموضوعات:

Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Reduction factor in different plant parts after exposure (14 days). حسب Yelena Polivkina (14341291)

الموضوعات:

Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. حسب Hong Tian (169626)

MiR-129-5p levels were decreased in mouse depression models. حسب Qiaozhen Qin (13159201)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: